SK285913B6 - Deriváty 5-substituovaného-3-oxadiazolyl-1,6-naftyridin-2(1H)-onu - Google Patents

Deriváty 5-substituovaného-3-oxadiazolyl-1,6-naftyridin-2(1H)-onu Download PDF

Info

Publication number
SK285913B6
SK285913B6 SK53-2000A SK532000A SK285913B6 SK 285913 B6 SK285913 B6 SK 285913B6 SK 532000 A SK532000 A SK 532000A SK 285913 B6 SK285913 B6 SK 285913B6
Authority
SK
Slovakia
Prior art keywords
group
alkyl
etoh
naphthyridin
oxadiazol
Prior art date
Application number
SK53-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK532000A3 (en
Inventor
Kazunori Ohno
Osamu Odai
Kaoru Masumoto
Kiyoshi Furukawa
Makoto Oka
Original Assignee
Dainippon Sumitomo Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co., Ltd. filed Critical Dainippon Sumitomo Pharma Co., Ltd.
Publication of SK532000A3 publication Critical patent/SK532000A3/sk
Publication of SK285913B6 publication Critical patent/SK285913B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK53-2000A 1997-07-15 1998-07-14 Deriváty 5-substituovaného-3-oxadiazolyl-1,6-naftyridin-2(1H)-onu SK285913B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20717997 1997-07-15
PCT/JP1998/003134 WO1999003857A1 (fr) 1997-07-15 1998-07-14 Derives de 5-substitue-3-oxadiazolyl-1,6-naphtyridin-2(1h)-one

Publications (2)

Publication Number Publication Date
SK532000A3 SK532000A3 (en) 2000-09-12
SK285913B6 true SK285913B6 (sk) 2007-11-02

Family

ID=16535559

Family Applications (1)

Application Number Title Priority Date Filing Date
SK53-2000A SK285913B6 (sk) 1997-07-15 1998-07-14 Deriváty 5-substituovaného-3-oxadiazolyl-1,6-naftyridin-2(1H)-onu

Country Status (29)

Country Link
US (2) US6172079B1 (xx)
EP (1) EP1010699B1 (xx)
JP (1) JP3390453B2 (xx)
KR (1) KR100508392B1 (xx)
CN (1) CN1134437C (xx)
AR (1) AR013222A1 (xx)
AT (1) ATE297923T1 (xx)
AU (1) AU735960B2 (xx)
BR (1) BR9811474B1 (xx)
CA (1) CA2296427C (xx)
DE (1) DE69830595T2 (xx)
DK (1) DK1010699T3 (xx)
EE (1) EE04372B1 (xx)
ES (1) ES2244065T3 (xx)
HK (1) HK1028895A1 (xx)
HU (1) HUP0004671A3 (xx)
ID (1) ID24047A (xx)
IL (2) IL133512A0 (xx)
NO (1) NO314999B1 (xx)
NZ (1) NZ501814A (xx)
PL (1) PL191200B1 (xx)
PT (1) PT1010699E (xx)
RU (1) RU2188199C2 (xx)
SI (1) SI1010699T1 (xx)
SK (1) SK285913B6 (xx)
TR (1) TR200000103T2 (xx)
TW (1) TW486479B (xx)
WO (1) WO1999003857A1 (xx)
ZA (1) ZA985870B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI298068B (en) 2000-06-21 2008-06-21 Dainippon Sumitomo Pharma Co Pharmaceutical composition for schizophrenia
TW200533371A (en) * 2004-04-15 2005-10-16 Dainippon Pharmaceutical Co Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
KR20090081407A (ko) 2006-10-25 2009-07-28 다이닛본 스미토모 세이야꾸 가부시끼가이샤 고결 방지 과립상 제제
ATE551342T1 (de) * 2008-02-22 2012-04-15 Irm Llc Heterocyclische verbindungen und zusammensetzungen als c-kit- und pdgfr- kinasehemmer
WO2010002451A1 (en) * 2008-07-01 2010-01-07 Concert Pharmaceuticals, Inc. Naphthyridin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415580A (en) * 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones
US4567186A (en) * 1985-01-14 1986-01-28 Sterling Drug Inc. 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
IL101860A0 (en) * 1991-05-31 1992-12-30 Ici Plc Heterocyclic derivatives
AU664912B2 (en) * 1992-09-02 1995-12-07 Dainippon Pharmaceutical Co. Ltd. Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
JP2002241379A (ja) * 1997-03-21 2002-08-28 Dainippon Pharmaceut Co Ltd 3−オキサジアゾリルキノキサリン誘導体

Also Published As

Publication number Publication date
CA2296427C (en) 2006-11-14
IL133512A0 (en) 2001-04-30
NO20000183D0 (no) 2000-01-14
NZ501814A (en) 2002-02-01
EE200000029A (et) 2000-10-16
DE69830595T2 (de) 2006-05-11
TR200000103T2 (tr) 2000-06-21
US6172079B1 (en) 2001-01-09
EE04372B1 (et) 2004-10-15
CN1264380A (zh) 2000-08-23
ZA985870B (en) 1999-01-27
CN1134437C (zh) 2004-01-14
HUP0004671A3 (en) 2001-12-28
KR20010021824A (ko) 2001-03-15
NO20000183L (no) 2000-03-07
NO314999B1 (no) 2003-06-23
US6277993B1 (en) 2001-08-21
AR013222A1 (es) 2000-12-13
RU2188199C2 (ru) 2002-08-27
SI1010699T1 (en) 2005-10-31
AU735960B2 (en) 2001-07-19
PT1010699E (pt) 2005-08-31
SK532000A3 (en) 2000-09-12
BR9811474A (pt) 2000-08-15
ES2244065T3 (es) 2005-12-01
PL338085A1 (en) 2000-09-25
ATE297923T1 (de) 2005-07-15
DK1010699T3 (da) 2005-10-10
WO1999003857A1 (fr) 1999-01-28
KR100508392B1 (ko) 2005-08-17
ID24047A (id) 2000-07-06
PL191200B1 (pl) 2006-03-31
HK1028895A1 (en) 2001-03-09
TW486479B (en) 2002-05-11
BR9811474B1 (pt) 2009-05-05
IL133512A (en) 2007-06-17
EP1010699B1 (en) 2005-06-15
HUP0004671A2 (hu) 2001-05-28
AU8129498A (en) 1999-02-10
CA2296427A1 (en) 1999-01-28
EP1010699A1 (en) 2000-06-21
DE69830595D1 (de) 2005-07-21
EP1010699A4 (en) 2001-09-12
JP3390453B2 (ja) 2003-03-24

Similar Documents

Publication Publication Date Title
WO1998042701A1 (fr) Derives de 3-oxadiazolylquinoxaline
JP2000515851A (ja) GABA▲下Aα5▼レセプターサブタイプの逆アゴニストとしての置換のあるトリアゾロピリダジン誘導体
NO324706B1 (no) Benzodiazepinderivater, fremstilling av disse, medikament inneholdende slike forbindelser samt anvendelse av disse for fremstilling av medikament for behandling av sykdommer
AU2010334591A1 (en) Inhibitors of AKT activity
DE69907923T2 (de) Triazolopyridazinderivate zur verbesserung der kognitiven funktionen
SK285913B6 (sk) Deriváty 5-substituovaného-3-oxadiazolyl-1,6-naftyridin-2(1H)-onu
US6613766B1 (en) Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptors
US6355638B1 (en) Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
RU2107686C1 (ru) Производное 3-оксадиазолил-5,6,7,8-тетрагидро-1,6-нафтиридина и производное 5,6,7,8-тетрагидро-1,6-нафтиридина
CN115348962A (zh) 作为GABAAα5受体调节剂的萘啶及吡啶并[3,4-c]哒嗪衍生物
CZ200046A3 (cs) Deriváty 5-substituovaného-3~oxadiazoIyl-l,6- naftyridin-2(lH)-onu
US6444666B1 (en) Triazolopyridazine Derivatives for treating anxiety and enhancing cognition
JPH11279176A (ja) 1,2,4−オキサジアゾリルキノロン誘導体
JPH0710874A (ja) 3−(1,2,4−オキサジアゾリル)−5,6,7,8−テトラヒドロ−1,6−ナフチリジン誘導体
JPH07126267A (ja) 1,3,4−オキサジアゾ−ル誘導体
MXPA00000558A (en) 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090714